199 related articles for article (PubMed ID: 37833790)
1. Cross talk of tumor protein D52 (TPD52) with KLF9, PKCĪµ, and MicroRNA 223 in ovarian cancer.
Khan K; Zafar S; Badshah Y; Ashraf NM; Rafiq M; Danish L; Shabbir M; Trembley JH; Afsar T; Almajwal A; Razak S
J Ovarian Res; 2023 Oct; 16(1):202. PubMed ID: 37833790
[TBL] [Abstract][Full Text] [Related]
2. Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression.
Zahra K; Shabbir M; Badshah Y; Trembley JH; Badar Z; Khan K; Afsar T; Almajwal A; Alruwaili NW; Razak S
Sci Rep; 2022 May; 12(1):8039. PubMed ID: 35577881
[TBL] [Abstract][Full Text] [Related]
3. Predicting 3D Structure, Cross Talks, and Prognostic Significance of
Safi S; Badshah Y; Shabbir M; Zahra K; Khan K; Dilshad E; Afsar T; Almajwal A; Alruwaili NW; Al-Disi D; Abulmeaty M; Razak S
Front Oncol; 2021; 11():797007. PubMed ID: 35047407
[TBL] [Abstract][Full Text] [Related]
4. Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer.
Khan K; Safi S; Abbas A; Badshah Y; Dilshad E; Rafiq M; Zahra K; Shabbir M
Biomed Res Int; 2020; 2020():1354381. PubMed ID: 33490232
[TBL] [Abstract][Full Text] [Related]
5. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
7. LINC01133 contribute to epithelial ovarian cancer metastasis by regulating miR-495-3p/TPD52 axis.
Liu S; Xi X
Biochem Biophys Res Commun; 2020 Dec; 533(4):1088-1094. PubMed ID: 33036757
[TBL] [Abstract][Full Text] [Related]
8. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.
Byrne JA; Balleine RL; Schoenberg Fejzo M; Mercieca J; Chiew YE; Livnat Y; St Heaps L; Peters GB; Byth K; Karlan BY; Slamon DJ; Harnett P; Defazio A
Int J Cancer; 2005 Dec; 117(6):1049-54. PubMed ID: 15986428
[TBL] [Abstract][Full Text] [Related]
9. MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.
Byrne JA; Maleki S; Hardy JR; Gloss BS; Murali R; Scurry JP; Fanayan S; Emmanuel C; Hacker NF; Sutherland RL; Defazio A; O'Brien PM
BMC Cancer; 2010 Sep; 10():497. PubMed ID: 20846453
[TBL] [Abstract][Full Text] [Related]
10. miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF9.
Shan L; Song P; Zhao Y; An N; Xia Y; Qi Y; Zhao H; Ge J
J Ovarian Res; 2022 May; 15(1):52. PubMed ID: 35501825
[TBL] [Abstract][Full Text] [Related]
11. microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
Han G; Fan M; Zhang X
Biochem Biophys Res Commun; 2015 Jan; 456(3):804-9. PubMed ID: 25511701
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
Yin W; Shi L; Mao Y
J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52).
Zhang Z; Wang J; Gao R; Yang X; Zhang Y; Li J; Zhang J; Zhao X; Xi C; Lu X
Oncol Res; 2017 May; 25(5):753-761. PubMed ID: 27983918
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
[TBL] [Abstract][Full Text] [Related]
15. Tumor protein D52 promotes breast cancer proliferation and migration via the long non-coding RNA NEAT1/microRNA-218-5p axis.
Ren J; Chen Y; Kong W; Li Y; Lu F
Ann Transl Med; 2021 Jun; 9(12):1008. PubMed ID: 34277808
[TBL] [Abstract][Full Text] [Related]
16. miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.
Ge J; Mao L; Xu W; Fang W; Wang N; Ye D; Dong Z; Guan H; Guan C
J Invest Surg; 2021 Sep; 34(9):984-992. PubMed ID: 32166986
[TBL] [Abstract][Full Text] [Related]
17. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
Zhang H; Li M; Zhang J; Shen Y; Gui Q
Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1323 downregulation promotes migration and invasion of breast cancer cells by targeting tumour protein D52.
Xu Y; Liu M
J Biochem; 2020 Jul; 168(1):83-91. PubMed ID: 32211853
[TBL] [Abstract][Full Text] [Related]
19. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N
FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of the expression levels of tumor protein D52 and miR-133a on prognosis assessment of pancreatic cancer surgery.
Wang ZY; Liu RH; Meng Y; Li JC
Pak J Med Sci; 2024; 40(4):723-729. PubMed ID: 38544991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
